Therapeutic Drug Monitoring of Oral Oncology Drugs: Finding the Right Nails
Clin Pharmacol Ther
.
2024 Sep;116(3):504-505.
doi: 10.1002/cpt.3368.
Epub 2024 Jul 1.
Authors
Niels A D Guchelaar
1
,
Maud B A van der Kleij
1
2
,
Neeltje Steeghs
2
3
,
Alwin D R Huitema
4
5
6
,
Ron H J Mathijssen
1
,
Stijn L W Koolen
1
7
Affiliations
1
Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.
2
Department of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
3
Department of Medical Oncology, University Medical Center Utrecht, Utrecht, The Netherlands.
4
Department of Pharmacy and Pharmacology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
5
Department of Clinical Pharmacy, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.
6
Department of Pharmacology, Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.
7
Department of Pharmacy, Erasmus Medical Center, Rotterdam, The Netherlands.
PMID:
38952193
DOI:
10.1002/cpt.3368
No abstract available
Publication types
Letter
MeSH terms
Administration, Oral
Antineoplastic Agents* / administration & dosage
Antineoplastic Agents* / adverse effects
Antineoplastic Agents* / pharmacokinetics
Drug Monitoring* / methods
Humans
Neoplasms / drug therapy
Substances
Antineoplastic Agents